Advisories For Registrants

June 17th, 2024
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site

June 10th, 2024
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access

June 6th, 2024
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine

Advisories For The Public

August 5th, 2024
Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

August 5th, 2024
JAMP Digoxin 0.0625 mg and 0.125 mg tablets recalled due to possible incorrect dose, which may pose health risks

July 29th, 2024
Various multivitamins and supplements distributed across Canada are being recalled because they may contain metal fibres

July 26th, 2024
Incorrect dosing information on the “SAVE ME” instructional card in the Naloxone Take Home Kit by Canadian Hospital Specialties Ltd

June 17th, 2024
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site

June 10th, 2024
Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns